Back
Abbott Laboratories 10K Form
Buy
62
ABT
Abbott Laboratories
Last Price:
117.61
Seasonality Move:
2.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-02 | 10Q | ABT/Abbott Laboratories Quarterly |
2024-02-16 | 10K | ABT/Abbott Laboratories Annual |
2023-11-01 | 10Q | ABT/Abbott Laboratories Quarterly |
2023-08-03 | 10Q | ABT/Abbott Laboratories Quarterly |
2023-05-04 | 10Q | ABT/Abbott Laboratories Quarterly |
2023-02-17 | 10K | ABT/Abbott Laboratories Annual |
Receive ABT News And Ratings
See the #1 stock for the next 7 days that we like better than ABT
ABT Financial Statistics
Sales & Book Value
Annual Sales: | $40.11B |
---|---|
Cash Flow: | $2.15B |
Price / Cash Flow: | 31.72 |
Annual Sales: | $22.94 |
Price / Book: | 5.13 |
Profitability
EPS (TTM): | 3.29000 |
---|---|
Net Income (TTM): | $5.77B |
Gross Margin: | $22.13B |
Return on Equity: | 14.78% |
Return on Assets: | 7.9% |
Abbott Laboratories Earnings Forecast
Key Abbott Laboratories Financial Ratios
- The Gross Profit Margin over the past 40 years for ABT is 55.18%.
- The Selling, General & Administrative Expenses for ABT have been equal to 27.30% of Gross Profit Margin.
- The Research & Development expenses have been 6.83% of Revenue.
- The Interest Expense is 11.13% of Operating Income.
- The Net Earning history of ABT is 14.27% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 29 years.
Abbott Laboratories Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | ABT |
CUSIP: | 002824 |
Website: | abbottinvestor.com |
Debt
Debt-to-Equity Ratio: | 0.38 |
---|---|
Current Ratio: | 1.6 |
Quick Ratio: | 1.14 |
Price-to-Earnings
Trailing P/E Ratio: | 36.09 |
---|---|
Forward P/E Ratio: | 22.81 |
ABT Technical Analysis vs Fundamental Analysis
Buy
62
Abbott Laboratories (ABT)
is a Buy
Is Abbott Laboratories a Buy or a Sell?
-
Abbott Laboratories stock is rated a Buy
The current Abbott Laboratories [ABT] share price is $117.65. The Score for ABT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.